EVOK icon

Evoke Pharma
EVOK

Overview Fund Activity

27 hedge funds and large institutions have $6.45M invested in Evoke Pharma in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+6
Holders Change %
+28.57%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Deutsche Bank
1
Deutsche Bank
Germany
$452K
2
SFM
2
Sphera Funds Management
Israel
$1.74M
3
6CM
3
683 Capital Management
New York
$258K
4
BRF
4
B. Riley Financial
California
$249K
5
Creative Planning
5
Creative Planning
Kansas
$226K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
VF
2
Virtu Financial
New York
$48K
3
TSS
3
Two Sigma Securities
New York
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.15M
5
FM
5
Family Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K – – –
Millennium Management
27
Millennium Management
New York
– -$183K -381 Closed
TSS
28
Two Sigma Securities
New York
– -$37K -77 Closed
FM
29
Family Management
New York
– -$35K -72 Closed
Bank of America
30
Bank of America
North Carolina
– -$33K -69 Closed
1
2